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Abstract
Background: Pituitary adenomas can give rise to a variety of clinical disorders and surgery is often the primary
treatment option. However, preoperative magnetic resonance imaging (MRI) does not always reliably identify the
site of an adenoma. In this setting molecular (functional) imaging (e.g. 11C-methionine PET/CT) may help with
tumor localisation, although interpretation of these 2D images can be challenging. 3D printing of anatomical
models for other indications has been shown to aid surgical planning and improve patient understanding of the
planned procedure. Here, we explore the potential utility of four types of 3D printing using PET/CT and co-
registered MRI for visualising pituitary adenomas.
Methods: A 3D patient-specific model based on a challenging clinical case was created by segmenting the
pituitary gland, pituitary adenoma, carotid arteries and bone using contemporary PET/CT and MR images. The 3D
anatomical models were printed using VP, MEX, MJ and PBF 3D printing methods. Different anatomical structures
were printed in color with the exception of the PBF anatomical model where a single color was used. The
anatomical models were compared against the computer model to assess printing accuracy. Three groups of
clinicians (endocrinologists, neurosurgeons and ENT surgeons) assessed the anatomical models for their potential
clinical utility.
Results: All of the printing techniques produced anatomical models which were spatially accurate, with the
commercial printing techniques (MJ and PBF) and the consumer printing techniques (VP and MEX) demonstrating
comparable findings (all techniques had mean spatial differences from the computer model of < 0.6 mm). The MJ,
VP and MEX printing techniques yielded multicolored anatomical models, which the clinicians unanimously agreed
would be preferable to use when talking to a patient; in contrast, 50%, 40% and 0% of endocrinologists,
neurosurgeons and ENT surgeons respectively would consider using the PBF model.
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Conclusion: 3D anatomical models of pituitary tumors were successfully created from PET/CT and MRI using four
different 3D printing techniques. However, the expert reviewers unanimously preferred the multicolor prints.
Importantly, the consumer printers performed comparably to the commercial MJ printing technique, opening the
possibility that these methods can be adopted into routine clinical practice with only a modest investment.
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Background
The pituitary gland plays a critical role in regulating the
body’s response to a variety of internal and external
stimuli. This is achieved through secretion of several key
hormones including adrenocorticotropic hormone
(ACTH), thyroid stimulating hormone (TSH), growth
hormone (GH), luteinizing hormone (LH) and follicle-
stimulating hormone (FSH). These hormones are re-
leased into the circulation and, in turn, direct hormone
release from key target tissues (e.g. thyroid, adrenal,
ovaries/testes, liver), thus modulating an array of physio-
logical processes, including cardiovascular function, me-
tabolism and reproductive function. Pituitary hormone
release is subject to negative feedback in which target
hormones, acting at both pituitary and hypothalamic
levels, diminish central hormone release. Autonomous
(unregulated) hormone production from a functioning
pituitary adenoma (PA, non-cancerous pituitary tumor)
can perturb this delicate equilibrium, manifesting a var-
iety of clinical syndromes including ACTH-dependent
Cushing’s syndrome (excess ACTH), acromegaly (excess
GH), hyperprolactinaemia (excess prolactin), and hyper-
thyroidism (excess TSH). The associated clinical symp-
toms can have a devastating impact on a patient’s
quality of life and some of these syndromes are also as-
sociated with higher mortality rates [1].
Surgery remains the mainstay of treatment for several
subtypes of PA. This is typically undertaken via the trans-
sphenoidal route, which offers both a safe and effective ap-
proach [2, 3]. However, incomplete resection can occur
depending on various factors, including adenoma size [4,
5] and proximity to adjacent vital structures such as the
carotid arteries contained within the cavernous sinuses,
which are located on either side of the pituitary gland [6,
7]. Additionally, transsphenoidal surgery (TSS) is not
without risk, with complications including cerebrospinal
fluid (CSF) leak and visual deterioration in the acute
phase, and hypopituitarism (ie loss of pituitary gland func-
tion) in the longer term [8]. Safe and effective surgery is
therefore heavily reliant on high quality preoperative im-
aging to allow accurate localisation of the adenoma. Mag-
netic resonance imaging (MRI) is the preferred modality
to assess the pituitary gland and surrounding structures
[9]. However, there are circumstances when the utility of
MRI in preoperative assessment is limited, in particular
adenomas less than 10mm (microadenomas) and/or
following recent pituitary surgery, where it can be difficult
to distinguish normal pituitary gland from residual aden-
omatous tissue and post-surgical changes [10]. Alternative
strategies to aid visualization of the pituitary gland have
been developed, in particular hybrid Positron Emission
Tomography (PET) with x-ray Computed Tomography
(PET/CT) [11–13] or MRI (PET/MR) [14, 15] which per-
mit correlation of function and anatomy. We have previ-
ously described the utility of [11C]-methionine in
Cushing’s syndrome [11], acromegaly [16] and TSHoma
[17].
Before deciding a patient’s management plan, pituitary
imaging is typically reviewed by a multidisciplinary team
(MDT), comprising of clinicians from various disciplines,
including endocrinology, neurosurgery and otolaryngol-
ogy [ear, nose and throat (ENT)], to determine suitability
for surgery and inform the choice of surgical approach
[18]. In addition, these images are also used during dis-
cussion with the patient preoperatively to explain the
proposed treatment. However, such 3D visualizations of
the pituitary gland and associated pathology may give
rise to several challenges: from the surgical perspective,
it can be difficult to fully appreciate adenoma location
and proximity to adjacent critical structures, even more
so in surgical revision cases; from a patient perspective,
it is often difficult to relate the 3D visualizations to their
own anatomy.
3D printing, based on cross-sectional imaging findings,
have begun to find use in other surgical disciplines to in-
form surgical planning and enhance patient understand-
ing [19]. Importantly, guidelines have been developed for
the use of 3D printing in clinical practice, including for
cardiac, hepatobiliary, gastrointestinal and other condi-
tions where it may have a potential role in informing
management [20–22]. However to our knowledge these
guidelines do not make specific mention to the pituitary
gland although a small number of studies have shown
the feasibility of 3D printing of pituitary tumors [23–25].
Here, we build on this work and demonstrate how
findings from anatomical and molecular (functional) im-
aging can be combined to produce 3D printed patient-
specific models. Based on a single complex pituitary
tumor case, we compare 3D printed models from both
commercial and consumer printers with a view to enab-
ling early, cost-effective adoption into routine clinical
practice.
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Methods
Imaging
MRI was performed on a GE Optima™ MR450w 1.5 T
scanner (GE Healthcare, Chicago, Illinois, United States)
using a Fast Spoiled Gradient Echo (FSPGR) sequence to
create a 3D volumetric dataset with 1 mm3 voxels and 1
mm spacing. PET/CT was performed using a GE Dis-
covery 690 scanner (GE Healthcare, Chicago, Illinois,
United States). The PET scan was acquired for 20 min at
20 min post administration of 390MBq of [11C]-methio-
nine (Wolfson Brain Imaging Centre, Cambridge). The
images were reconstructed using GE’s Sharp Iterative
Reconstruction (SharpIR) algorithm with CT measured
attenuation correction, scatter correction and time of
flight using 2 iterations and 24 subsets with a 3.2 mm
Gaussian filter. The CT scan acquired with 140 kV, fixed
mA of 220, a rotation speed of 0.5 s, a pitch of 0984:1,
30 cm field of view, a slice thickness of 1.25 mm and a
1.25 mm spacing interval. The CT was reconstructed
using filtered back projection.
Image segmentation
To prepare the images for segmentation, the CT was
registered to the volumetric MRI using 3D Slicer [26]
(version 4.10.2, 05–2019). A rigid registration was used
with 6 degrees of freedom, maximum number of itera-
tions of 1500 and a sampling ratio of 0.1%. The resulting
transformation was applied to the PET images so that all
three imaging modalities were co-registered (PET/CT +
MR).
Using 3D Slicer the pituitary gland and tumor were
segmented on the MRI with the PET image overlaid
(Fig. 1). This segmentation was a predominantly manual
process that was guided by the PET and with pituitary
regions-of-interest drawn on to each slice of the MRI.
The carotids were outlined using a voxel thresholding
tool on the MRI. The initial carotid segmentation in-
cluded some unwanted structures which were removed
using the cutting tool in 3D Slicer. Only vessels adjacent
to the pituitary gland and tumor (within approximately
30 mm) were included in the model (Fig. 1).
Fig. 1 Segmentation of the pituitary gland and adjacent structures. A–F, Pituitary gland (blue) and pituitary tumor (yellow) segmentation using
PET registered with MRI. G, 3D rendered model of pituitary gland (white structure) and pituitary tumor (yellow structure). H–J, Bone
segmentation from CT using thresholding tool. K, 3D rendered model of bone after removal of small islands and imaging bed. L–M, Carotid
arteries segmentation with FSPGR MR using thresholding tool. N, Initial 3D rendered segmentation of MR soft tissue. O, Final segmentation of
carotid arteries after unwanted structures have been removed
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The skull was segmented from the CT using voxel
Hounsfield unit (HU) values between 100 HU and the
maximum HU in the image (Fig. 1). Small floating struc-
tures within this segmentation were removed using the
‘Islands’ tool and the imaging bed was also removed.
The final segmentations were agreed together with ex-
pert reviewers with experience in neuroradiology and
molecular imaging, specifically [11C]-methionine PET in-
terpretation, to ensure that the boundaries of the seg-
ments conformed to the corresponding anatomical
structures (using MR and CT) and functional uptake on
PET.
Model preparation for 3D printing
All the structures were smoothed using a median
smoothing filter of 3 mm. The model was limited to the
structures between the centre of each orbit, inferior to a
horizontal plane superior to the supraorbital ridge. The
part of the skull base posterior to the clivus was also re-
moved. This process limited the amount of material
required for the print but retained all of the structures
needed for surgical planning such as the nasal cavity and
the bones at the base of the skull surrounding the pituit-
ary gland.
The resulting individual segmentations were brought
together using 3D Slicer to form a final model compris-
ing the pituitary gland, pituitary tumor, carotids and sur-
rounding bone (Fig. 2). The final model was prepared
differently depending on the type of printing technique.
For powder bed fusion (PBF) printing, the segments
were added together and printed monochromatically
(white). Multi-material material extrusion (MEX) and
material jetting (MJ) are multicolor techniques and for
these each segment was assigned a color during the
printing setup (pituitary gland [blue], adenoma [yellow],
carotids [red], bone [white]). Monocolor vat photopoly-
merization (VP) permits the use of transparent resin; ac-
cordingly, the pituitary gland, pituitary tumor and
carotid segments could be made hollow to allow intro-
duction of colored resin after printing. The hollowing
Fig. 2 Final 3D rendered model. A, Oblique view, B, lateral view, C, postero-superior view and D, view through the previous surgical opening
(which has left a bony defect) in the floor of the pituitary fossa. Blue arrows indicate location of normal pituitary gland, yellow arrows indicate
location of adenoma and red arrows indicate location of carotid arteries. The green arrow indicates the trajectory of the surgical approach via the
trans-nasal route
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process was automated by specifying the wall thickness
(0.5 mm) and position of the wall (median surface). This
process resulting in a 0.25 mm internal and a 0.25 mm
external thickening of the boundary. After combining
the segments small discrete holes were created in the pi-
tuitary gland, tumor and carotid segments to facilitate
the addition of the different colored resin. The final ver-
sions of the model for all printing techniques were
exported from 3D Slicer as Standard Tessellation
Language (STL) files.
3D printing techniques
The PBF anatomical model was printed on a EOS100
printer with a resolution of 0.1 mm using Nylon PA2200
by an external commercial provider (3DPRINTUK, Ley-
ton, UK). The STL file was uploaded to the website and
it was subsequently printed using a single color (white)
nylon material.
The MJ anatomical model was printed on a Stratasys
J750 printer with a layer height of 0.014 mm by an exter-
nal supplier (Laserlines, Banbury, UK). The STL files
were sent to the company with each structure being
assigned a different color (bone - white, pituitary - blue,
pituitary tumor - yellow, carotids - red). These same
colors were also used for the MEX and VP anatomical
models.
MEX printing was carried out at our institution using
a Prusa Research MK3 with a Multiple Material Unit
(Prusa Research, Prague, Czech Republic). The STL files
were prepared for printing using PrusaSlicer and
exported as gcode. Four colored PETG filaments were
used to print using a layer height of 0.2 mm and a 0.4
mm nozzle resulting in a print time of 24 h (Figs. 3, 4, 5
and 6). PETG was preferred over PLA to minimise the
risk of color fading with time. The anatomical model
was printed with support structures which were re-
moved afterwards.
VP printing was carried out in-house using a Prusa
Research SL1 (Prusa Research, Prague, Czech Republic)
and a transparent resin. The STL files were prepared for
printing using PrusaSlicer and exported as masked SLA
files (.SL1 files). A layer height of 0.05 mm with exposure
Fig. 3 Angled views of anatomical models. Images of A, VP, B, MEX, C, MJ and D, PBF anatomical models. Blue arrows indicate location of
pituitary gland, yellow arrows indicate location of adenoma and red arrows indicate location of carotid arteries
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times of 35 s and 6 s were used for the initial layers and
subsequent layers respectively. Printing took eight hours.
Immediately after the printing finished the anatomical
model was washed in Isopropyl Alcohol 99% (IPA) for
10 min. The anatomical model and its support structures
were then removed from the printing plate, dried using
hot air for five minutes and cured with ultraviolet radi-
ation (UV) for five minutes. The voids were then filled
with colored printing resin using a syringe and a 19
gauge needle before being cured again for another five
minutes (Panel A in Figs. 3, 4, 5 and 6). The washing,
drying and curing were all carried out using a Prusa Re-
search CW1 (Prusa Research, Prague, Czech Republic).
Anatomical model evaluation
Each anatomical model was evaluated for i) accuracy
and ii) perceived clinical utility.
i) Accuracy was assessed through comparison of five
measurements (height, width and depth of the
models and diameters of two small landmarks in
the skull base) determined on the anatomical
models and on the computer model (using 3D
slicer) see Fig. 7 for measurement locations.
Assessment of the printed anatomical models was
performed by two blinded operators (DG and DM)
using a calibrated height gauge and calibrated
calipers. The operators came to a consensus on
each measurement. The differences between the
computer model and the printed anatomical models
were used to assess printing accuracy.
ii) Clinical utility was assessed by three groups of
clinicians (endocrinologists, ENT surgeons and
neurosurgeons) by filling out a questionnaire. The
following questions and answer scaling were used:
1. How useful do you think this model would be in
informing the patient about their disease? (Very
Poor [1], Poor [2], Acceptable [3], Good [4], Very
Good [5])
Fig. 4 Lateral views of anatomical models. Left lateral images A, VP, B, MEX, C, MJ and D, PBF anatomical models. Yellow arrows indicate
location of adenoma and red arrows indicate location of carotid arteries. Green arrows indicate where the surgeons enter the nose to access the
pituitary gland through the pituitary sella, which is shown in Fig. 6 for all anatomical models
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2. How useful do you think this model would be in
informing the patient about their surgery? (Very
Poor [1], Poor [2], Acceptable [3], Good [4], Very
Good [5])
3. Do you think the use of a model like this would
change patient care? (Definitely not [1], Probably
not [2], Possibly [3], Probably [4], Definitely [5])
4. How useful do you think this model would be for
training other clinicians/surgeons? (Very Poor [1],
Poor [2], Acceptable [3], Good [4], Very Good [5])
5. Overall how would you rate the quality of the
model? (Very Poor [1], Poor [2], Acceptable [3],
Good [4], Very Good [5])
6. Would you like to use a model like this when
talking to a patient? [Yes or No]
7. How much would you pay for this model? (£)
8. Any additional comments
The results for questions 1 to 6 were visualised and
compared using the Likert function in the statistical
package R [27]. For Question 7, the average amount that




Segmenting the structures of interest (Fig. 1) took ap-
proximately 90 min, with the majority of this time being
spent on manually segmenting the pituitary gland and
the pituitary adenomas (see Fig. 1 panels A-G). In con-
trast, the bone segmentation was performed using a
semi-automated threshold technique with the only man-
ual intervention being to define the extent of the sur-
rounding bone included in the final print (see Fig. 1
panels H-K). The process was similar for the carotid ar-
teries but more manual intervention was required be-
cause of the limited contrast between the arteries and
the surrounding tissue on MRI (see Fig. 1 panels L-O).
For the VP anatomical model, additional steps were
required to allow the creation of hollow structures. A
shell thickness of 0.5 mm was centred on the surface of
the structure. This resulted in the boundary moving
Fig. 5 Posterior views of anatomical models. Posterior images of A, VP, B, MEX, C, MJ and D, PBF anatomical models. The blue arrows indicate
location of pituitary gland, the yellow arrows indicate location of adenoma and the red arrows indicate location of carotid arteries
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Fig. 6 Views from the nose (as per the transsphenoidal surgical approach) of the anatomical models. Images from the nose of A, VP, B, MEX, C,
MJ and D, PBF anatomical models. The blue arrows indicate the location of the pituitary gland and the yellow arrows indicate the location of the
adenoma. The red arrows on panel A highlight that the carotid arteries are visible through the transparent bone of the VP anatomical model. The
grey arrows on panel B highlight that the remnant support structures are still visible through opening in bone on the MEX anatomical model
Fig. 7 Assessment of printing accuracy. The five distances used to assess printing accuracy were the depth, height and width of the models,
together with two small (< 1 cm) landmarks in the skull base (A and B). The depth, height and width were determined as shown with a height
gauge. Both small landmarks were measured using callipers
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outwards 0.25 mm and inwards 0.25 mm which provided
the optimal compromise between the size of the cavity
for resin injection versus encroachment on adjacent
structures.
3D printing
The commercial printing options - MJ and PBF - were
simple to use as they did not require any knowledge of
the printing processes which were outsourced. In con-
trast, the consumer printing options - VP and MEX - re-
quired local expertise/knowledge and as a result the
consumer printers were associated with additional
preparation costs and required trained staff.
The consumer printers - VP and MEX (Figs. 3A-B,4A-
B,5A-B and 6A-B) - were able to produce anatomical
models more quickly than the commercial printers - MJ
and PBF (Figs. 3C-D,4C-D,5C-D and 6C-D) - because
they could be used on site whereas the commercially
printed models had to be posted to us. The VP, MEX,
MJ and PBF anatomical models were produced and
received in 0.3, 1.0, 30 and 14 days, respectively.
Cost
The cost per model for the consumer printers - VP and
MEX - was calculated by factoring in the time required
by technical staff to set up the printer and finish the
print, the cost of materials and the cost of the printer
itself.
For the VP and MEX anatomical models, part of the
estimated costs was based on each method taking ap-
proximately two hours of a technician’s time. For MEX
printing this time is split between setting up the printer
for the desired materials and starting the printing (30
min) and removing the support structures (90 min).
However, if dissolvable support structures could be used,
this time, and therefore cost, could be reduced. For the
VP printing this time was divided between setting up the
printer with the material (15 min), washing and curing
the printed anatomical model (30 min), removing the
support structures (30 min) and filling the hollow struc-
tures (45 min).
The mean cost per model when the cost of the printer
itself is taken into account is therefore affected by the
number of models each printer produces. As this is an
unknown quantity, 10 and 100 prints have been used to
allow for an arbitrary comparison, representing a rela-
tively low and relatively high usage. The cost per model
for the commercial printing techniques - MJ and PBF -
was simply taken as the price paid for the models. As a
result the VP and MEX techniques have potential ranges
of £76 to £220 and £70 to £160 respectively. The PBF
technique is comparable in cost to consumer printers
whereas the MJ printer is approximately double the cost.
The data is summarised in Table 1.
Print accuracy
The accuracy of the printing dimensions was assessed in
five positions (see Fig. 7). Figure 8 shows the mean and
range of the differences taken from the printed anatom-
ical models and the computer models (a single one ana-
tomical model used for each printing technique). The
maximum differences were less than 0.7 mm for all
models.
The PBF anatomical model had excellent printing ac-
curacy and was the only anatomical model that had no
visible layer lines and no imperfections. The MJ and VP
anatomical models had almost as good printing accuracy
and only had visible layer lines when the anatomical
models were inspected closely (see Fig. 6 - panel B).
However, the VP anatomical model had visible imperfec-
tions where the resin was added to the hollow cavities
and on the MJ anatomical model the anterior cerebral
arteries were easily damaged as they were very slender.
The MEX anatomical model had easily visible layer lines
and the worst spatial accuracy but it was still well within
the predefined 1 mm accuracy threshold (see Fig. 7). Un-
fortunately this anatomical model had visible remnants
of the internal support structures where they were not
able to be completely removed, as indicated in Fig. 6
panel B.
Perceived clinical utility
The PBF anatomical model had the lowest rating for
questions 1–6 from all three groups of clinicians. The
PBF anatomical model was the only monocolor anatom-
ical model and this was given as the reason for its poor
performance in the questionnaire comments.
On average the multicolor anatomical models were all
rated positively for usefulness in informing the patient
about their disease. The MEX anatomical model was
favoured by the endocrinologists and the VP was
favoured by the neurosurgeons and ENT surgeons.
As a general rule, the multicolor anatomical models
were rated positively for their usefulness in informing
the patient about their surgery. The MJ anatomical
model received the highest score from the Endocrinolo-
gists and the VP anatomical model was awarded the
highest score by the neurosurgeons and ENT surgeons.
The endocrinologists and ENT surgeons concluded
that all three multicolored anatomical models could po-
tentially change patient management. However, the neu-
rosurgeons adopted a more neutral position, indicating
it was possible but not probable they would change pa-
tient management; they did not express a preference
with all three multicolor anatomical models scoring the
same.
The multicolor anatomical models were rated posi-
tively for their potential utility in training other clini-
cians. The MEX and MJ anatomical models both had
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the highest rating from the endocrinologists, whereas
the VP anatomical model was preferred by both the
ENT surgeons and the neurosurgeons.
From a print quality perspective, the colored anatom-
ical models were preferred, with the MJ anatomical
model rated highest by the Endocrinologists and the VP
anatomical model rated highest by the ENT surgeons
and neurosurgeons.
All clinicians indicated they would welcome the
opportunity to have any of the multicolored anatomical
models available when consulting with a patient.
The results of questions 1–6 of the questionnaire are
summarised for the endocrinologists (n = 6), ENT
surgeons (n = 3) and neurosurgeons (n = 5) in Fig. 9.
The results of question 7 (estimating the monetary
worth of each anatomical model) were combined for all
expert groups and are shown in Table 2.
Discussion
We have shown that consumer printers are able to pro-
duce accurate 3D printed anatomical models of pituitary
tumors segmented using a combination of structural (CT
and MRI) and functional ([11C]-methionine PET) imaging.
In a previous study of patients with malignant brain
tumors (glioma), a 3D printing approach was shown to
improve patient understanding and support clinical deci-
sion making [28]. For patients with pituitary tumors 3D
printed anatomical models have been proposed for
Table 1 Cost analysis. Cost for printing preparation and finishing assumed to be £25 per hour. The materials differ between the VP
and MEX but the costs are approximately the same per anatomical model. The estimated cost per model for the low-cost consumer
printers - VP and MEX - is based on each printer printing 10 or 100 models
Cost analysis (£) VP MEX MJ PBF
Printing prep and finishing 50.00 50.00 N/A N/A
Materials 10.00 10.00 N/A N/A















Key: MEX Material Extrusion, MJ Material Jetting, PBF Powder bed fusion, VP Vat Photopolymerization.
Fig. 8 Print accuracy. The differences in measurements (mm) between computer models and printed anatomical models are shown as means
(blue dots) and ranges (black bars) for each printing technique
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enhancing surgical training [23, 24]. A particular focus
of these early models has been the visual appearance
and aesthetics with respect to mimicking human tissue.
Other workers have explored the use of 3D printed
patient-specific models to inform surgical planning, and
have demonstrated benefits in terms of operative dur-
ation and volume of blood loss in a group of 10 patients
(compared with control subjects undergoing surgery not
informed by a 3D anatomical model) [25].
We have previously reported the potential utility of 3D
rendered models, which combine data from anatomical
imaging (MRI and CT) with molecular (functional)
imaging using [11C]-methionine PET/CT, in the man-
agement of patients with pituitary tumors [29]. Specific-
ally, in patients with persistent disease following initial
surgery, and in whom there is uncertainty regarding the
resectability of residual tumor, we have shown that 3D
rendered models can aid distinction between the tumor
Fig. 9 Responses to questionnaire. The position of each horizontal bar indicates the relative weighting of negative (1–2), neutral (3) and positive
(4–5) responses, with the bar moving progressively further to the right as the number of positive responses increased. The colors of the bars
denote the proportion of the responses which were assigned to each option on the respective Likert scales as shown in the panel at the bottom
of the figure
Table 2 Mean estimates of monetary worth for each anatomical model
Results of question 7 (£) VP MEX MJ PBF
Mean worth and range according to clinicians 82 (10 to 400) 83 (15 to 300) 88 (20 to 300) 45 (0 to 200)
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and surrounding normal tissues and inform the surgical
approach [26].
Segmenting the structures of interest involved manu-
ally drawing around the pituitary gland and tumor (Fig.
1 panels A-F). This process was aided by incorporation
of PET datasets, co-registered to the MRI, thus allowing
the active tumor (often best seen on the functional im-
aging) to be more readily distinguished from postopera-
tive scar tissue. Semi-automatic segmentation tools, such
as thresholding, could not differentiate between the pitu-
itary gland, pituitary adenomas and surrounding tissues.
However, the use of artificial intelligence-driven segmen-
tation, which has shown promise in brain tumors includ-
ing pituitary tumors [30], may allow this process to be
automated. In contrast, bone was readily segmented (See
Fig. 1 panels H-K) and we anticipate this aspect could be
completely automated in future studies. The bone was a
key part of the final model, which emphasises the need
for CT - or ultrashort echo time MR sequences - to per-
mit bone segmentation. At the time of the study, the
commercial printing techniques - MJ and PBF - had lead
times of 2 weeks or more and, accordingly, if they were
to be adopted into routine clinical practice this delay
would need to be taken into account. However, many
printing services now offer lead times of 2–4 days, which
would minimise any potential impact on clinical
decision-making. These printing techniques also have
advantages over the consumer printing techniques - VP
and MEX - because they are readily accessible and do
not require the institution to have specialist equipment
or staff trained in 3D printing. In contrast, the consumer
printing techniques offer the advantage of more rapid
turnaround (less than 2 days) of the appropriate imaging
being obtained. Another important consideration in
assessing the feasibility of these printing techniques was
the accuracy of the printed anatomical model compared
to the computer model. The measurements taken from
the anatomical models (see Fig. 7) demonstrated that all
of the techniques had mean differences of less than 0.5
mm (see Fig. 8) with the PBF, VP and MJ anatomical
models having marginally smaller differences to the
MEX anatomical model.
The VP technique required additional manipulations
to deliver a multicolored anatomical model, which in-
volved two distinct steps: firstly, segmentations of the ca-
rotid arteries, normal pituitary gland and tumor were
hollowed out and added to the bone segment to create
one object that could be printed. This allowed the result-
ing structure to be printed without internal supports
and to be filled with liquid resin. To ensure the hollow
structures were printed successfully, it was necessary to
strike a balance: the shell needed to be thick enough to
support itself during printing but not too thick (other-
wise the internal cavity would be too small). In addition,
a small discrete hole was also required to enable injec-
tion of the colored resin. After each cavity was filled the
model required curing with UV radiation to solidify the
colored resin. Importantly, the model was cured in an
orientation that would not allow the resin to flow out of
the cavity. These two steps therefore added additional
complexity and time to the creation of this model.
The MJ and MEX anatomical models had a similar ap-
pearance with both incorporating solid colors depicting
the tissues of interest (see Figs. 3, 4, 5 and 6 panels B
and C). However, remnants of the support structures
detracted from the overall appearance of the MEX ana-
tomical model (Fig. 6 panel B). To overcome this prob-
lem, future models could be printed with dissolvable
supports [31]. However, this would require (i) the use of
support material that is compatible with the thermoplas-
tic, such as PolyVinyl Alcohol (PVA) and (ii) a MEX
printer capable of using multiple materials. The VP ana-
tomical model used similar colors but had a different ap-
pearance because the bone was transparent and the
pituitary gland, tumor and carotid arteries were all
slightly enlarged by the process of hollowing them out
(see Figs. 3, 4, 5 and 6 panel A). Lastly, the PBF anatom-
ical model lacked color and consequently contrast be-
tween the tissues of interest (see Figs. 3, 4, 5 and 6 panel
D). Whilst the anatomical model could be painted after
printing, this process would be dependent on the inter-
pretation of the painter which could result in errors.
Perceived clinical utility
The PBF anatomical model performed poorly across the
board. All clinicians gave a rating of neutral or below for
questions 1 to 5. Importantly, only 50% of the endocri-
nologists, 40% of the neurosurgeons and 0% of the ENT
surgeons said they would like to use this anatomical
model in clinical practice compared to 100% of all
groups for the other types of anatomical models (see Fig.
8). Therefore, it seems unlikely that this type of anatom-
ical model would be readily adopted into routine clinical
practice. Specifically, the lack of colors depicting the dif-
ferent structures was considered a significant limitation,
and is something which has been highlighted by other
workers [23].
The MEX and MJ anatomical models were favoured
by the endocrinologists while, in contrast, the VP ana-
tomical model was preferred over the MEX and MJ ana-
tomical models by the ENT surgeons. However, all three
anatomical models were considered equivalent by the
neurosurgical group. Importantly, although the MEX
and MJ anatomical models were rated similarly by the
endocrinologists, the MJ anatomical model cost almost
five times as much as the MEX anatomical model, which
is a potentially important consideration for clinical
translation.
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The ENT surgeons commented that the transparent
bony material used in the VP anatomical model offered
potential benefits as this allowed them to visualise the
exact position of the carotid arteries through the bone -
an important consideration when planning a transnasal
surgical approach to the pituitary gland. The neurosur-
geons commented in the questionnaire that the add-
itional inclusion of the optic nerves and chiasm would
be useful. The optic nerve is easily seen on the MR im-
ages and so could readily be included in future versions
of these anatomical models. For example, the MEX
printing method employed in this study is capable of
using five different materials, whilst the MJ printing
method offers even more color possibilities, and would
therefore enable structures such as the optic nerves/chi-
asm to be printed in a discrete color. It is important to
note however, in the case of the MEX printing method
used here this would prohibit the use of dissolvable sup-
ports. A potential solution for this is to print some of
the structures separately and retrospectively add them to
the anatomical model [24]. We decided against this ap-
proach because of the risk of introducing errors in the
relative positioning of the different structures when con-
structing the final anatomical model.
Cost analysis
The cost of the printer is an important consideration
when estimating the cost per model for the consumer
printers and one which is potentially more complicated
than can be fully captured in Table 1. For example, we
have made two fundamental assumptions about each
consumer printer (i) it needs to be purchased in full and
(ii) it is solely used for printing these anatomical models.
Both are not the case at our institution. However, if we
take a conservative approach and consider the costs as-
sociated with creating 10 to 100 printed anatomical
models, this provides a starting metric for comparison
with the commercial printers. At 10 models per printer,
the cost per model for VP and MEX would be £220 and
£160 respectively and thereby highlighting that only a
small number of models would need to be printed to
make either of these options more financially viable than
the commercial MJ printed anatomical model. Of
course, it is also possible that the cost of the MJ prints
would fall slightly in the context of a larger scale pur-
chase of such models.
Limitations
An important limitation of our work is that it was based
on only a single representative clinical case. Neverthe-
less, this was a challenging and illustrative case, as the
patient had undergone previous pituitary surgery and
the suspected residual adenoma was at the lateral aspect
of the pituitary fossa. In this work, our intention was to
establish the feasibility, cost effectiveness and clinical ac-
ceptability of such 3D printed pituitary models and not
to capture the full range of pre-surgical pituitary abnor-
malities, as reflected by 3D printed models. One of the
next steps for this work will be to prospectively use ana-
tomical models with patients to explore their usefulness
in clinical practice as a tool for patient education and
eliciting informed consent.
Conclusion
In conclusion, we have shown that it is feasible to create
accurate 3D anatomical models of pituitary tumors, to-
gether with the adjacent normal gland and surrounding
critical structures (e.g. carotid arteries), using four differ-
ent 3D printing techniques, each based on PET/CT cor-
egistered with volumetric MRI. We have also
demonstrated that clinicians from different specialties
have overlapping, but discrete preferences for the differ-
ent anatomical models based on specific priorities (e.g.
ENT surgeons identified additional value from the VP
anatomical model with its transparency). Importantly,
the consumer printing techniques (VP and MEX) per-
formed just as well as the commercial printing techniques
(MJ and PBF), and were considerably less expensive, with
the potential for up-scaling and therefore more wide-
spread adoption into routine clinical practice.
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